Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.9K Sell
39,573
-10,335
-21% -$7.78K 0.01% 72
2025
Q4
$43.8K Sell
49,908
-714,154
-93% -$763K 0.03% 67
2025
Q3
$1.04M Hold
764,062
0.78% 35
2025
Q2
$1.2M Sell
764,062
-100,000
-12% -$186K 1.19% 25
2025
Q1
$2.28M Buy
864,062
+100,000
+13% +$401K 1.98% 14
2024
Q4
$3.24M Buy
764,062
+249,062
+48% +$960K 2.64% 10
2024
Q3
$1.71M Buy
515,000
+55,000
+12% +$187K 1.48% 19
2024
Q2
$1.42M Hold
460,000
1.31% 20
2024
Q1
$1.86M Buy
460,000
+310,000
+207% +$1.17M 1.51% 16
2023
Q4
$839K Buy
150,000
+20,000
+15% +$115K 0.66% 30
2023
Q3
$693K Buy
130,000
+20,000
+18% +$162K 0.59% 29
2023
Q2
$1.03M Hold
110,000
0.77% 24
2023
Q1
$952K Hold
110,000
0.75% 20
2022
Q4
$778K Hold
110,000
0.55% 25
2022
Q3
$1.09M Hold
110,000
0.77% 26
2022
Q2
$785K Hold
110,000
0.57% 28
2022
Q1
$1.02M Buy
110,000
+100,000
+1,000% +$753K 0.73% 24
2021
Q4
$94K Buy
+10,000
New +$92.8K 0.06% 64

Other funds holding DCGO

Birchview Capital's DCGO Position: Q1 2026 in Review

Birchview Capital reduced its DocGo (DCGO) stake by 21% in Q1 2026, selling an estimated $7.78K and leaving 39,573 shares worth $24.9K. The position accounts for 0.01% of the portfolio, ranked #72.

Birchview Capital first reported a position in DCGO in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.24M in Q4 2024. 122 funds tracked by Wall St. Rank hold DCGO as of Q1 2026.

  • Birchview Capital held 39,573 shares of DocGo worth $24.9K as of Q1 2026.
  • Birchview Capital sold 10,335 DocGo shares in Q1 2026, an estimated $7.78K.
  • DocGo made up 0.01% of Birchview Capital's portfolio in Q1 2026, its #72 holding.
  • Birchview Capital first reported a position in DocGo in Q4 2021 and has held it in 18 quarters since.
  • Birchview Capital's DocGo position peaked at $3.24M in Q4 2024.
  • 122 funds tracked by Wall St. Rank held DocGo as of Q1 2026.

Based on Birchview Capital's 13F filing for Q1 2026, filed 15 May 2026.